Company
Pfizer Inc
NYSE:PFE
Pfizer Inc is a research-based biopharmaceutical company. The company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. The Company operates through two segments: Biopharma and PC1.
293 stories · page 4 of 15
Pfizer legal woes continue with battle against Moderna
Pfizer and BioNTech are countersuing rival Moderna in a legal battle over the development of covid vaccines
Pfizer raises sales forecasts, despite ongoing legal challenges
Pfizer hiked annual forecasted sales of its COVID-19 vaccine by US$2bn, despite extensive legal trouble
Pfizer raises price of Covid vaccine in US by four-fold
A director told Reuters the new price for the jab will be around US$110-130 compared to US$30 currently
Pfizer to buy Global Blood Therapeutics for US$5.4bn
Pfizer gets Oxybryta and two other pipeline assets with the acquisition - and approved GBT drugs are expected to generate over US$3bn in sales annually at their peak
BioNTech and Pfizer in talks to delay Covid vaccine deliveries amid EU glut
A contract has been signed with the EU for up to 1.8bn doses of the jab, though the contract only extends to 2023
BioNTech sued by CureVac over its mRNA technology
BioNTech and two subsidiaries have been accused of infringing on the Germany-based biotech company's intellectual property rights, with Curevac seeking 'fair compensation'
Pfizer pledges not to make a profit on third world vaccines in future
The pharmaceutical company made $42.6bn from the sale of vaccines in 2021
Pfizer/BioNTech say third vaccine dose is 80% effective against Omicron in kids 5 and younger
According to clinical trial results released Monday, a third vaccine dose was well tolerated by the children, and most side effects were mild to moderate
Pfizer splashes $11.6bn of vaccine cash on Biohaven Pharmaceutical Holding
Will this be the start of the predicted rash of biotech M&A activity?
Pfizer accused of profiteering after reporting further leap in Covid vaccine sales
Other companies such as AstraZeneca and Johnson & Johnson priced their vaccines at cost during the pandemic
Pfizer leaves 2022 COVID-19 product sales forecasts unchanged in 1Q report
The firm previously increased its guidance for vaccine sales after each quarter in 2021
Moderna requests emergency approval for a second Covid booster for all adults
The request was based in part on recent data from the United States and Israel regarding how well the Moderna shot warded off the Omicron variant of the Corona virus
Archive
Wall Street closes higher as investors await inflation data
The Nasdaq Composite was up by 1.3% at 14,194, followed by the Dow Jones Industrial Average that rose by 1%, or 372 points at 35,463, while S&P 500 gained 0.8% at 4,521
Pfizer and BioNTech set to begin trials of Omicron specific vaccine
The proposed vaccine will be trialed among 1,420 adults between the ages of 18-55
Pfizer's COVID-19 pill given green light by the FDA
The FDA said the pill "is not a substitute for vaccination in individuals for whom COVID-19 vaccination and a booster dose are recommended"